גסטרואנטרולוגיה ומחלות כבד
המרכז למחקר רפואי פלסנשטיין

חקר הכבד

המרכז למחקר רפואי פלסנשטיין

ראשי המחקר שלנו פרסומים נבחרים הצוות לכל המעבדות

חקר הכבד

פרסומים נבחרים

2006

  • PGC-1alpha controls hepatitis B virus through nutritional signals.
    Shlomai A, Paran N, Shaul Y
    Proc Natl Acad Sci U S A. 2006;103:16003-8
    למחקר

2008

  • The "metabolovirus" model of hepatitis B virus suggests nutritional therapy as an effective anti-viral weapon.
    Shlomai A, Shaul Y.
    Med Hypotheses. 2008;71:53-7
    למחקר

2009

  • The "Trojan horse" model-delivery of anti-HBV small interfering RNAs by a recombinant HBV vector.
    Shlomai A, Lubelsky Y, Har-Noy O, Shaul Y.
    Biochem Biophys Res Commun. 2009;390:619-23
    למחקר
  • The metabolic activator FOXO1 binds hepatitis B virus DNA and activates its transcription.
    Shlomai A, Shaul Y.
    Biochem Biophys Res Commun. 2009;381:544-8
    למחקר

2010

  • Ectopic splenomegaly.
    Shlomai, A., and Guzner-Gur, H.
    Intern Med J 2010;40:600
    למחקר
  • Predictors of pandemic (H1N1) 2009 virus positivity and adverse outcomes among hospitalized patients with a compatible syndrome.
    Shlomai A, Nutman A, Kotlovsky T, Schechner V, Carmeli Y, Guzner-Gur H.
    Isr Med Assoc J. 2010;12:622-7
    למחקר
  • Large-scale population analysis reveals an extremely low threshold for "non-healthy" alanine aminotransferase that predicts diabetes mellitus.
    Shlomai A, Kariv R, Leshno M, Beth-Or A, Sheinberg B, Halpern Z.
    J Gastroenterol Hepatol. 2010;25:1687-91
    למחקר
  • Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1alpha.
    Rechtman MM, Har-Noy O, Bar-Yishay I, Fishman S, Adamovich Y, Shaul Y, Halpern Z, Shlomai A.
    FEBS Lett. 2010;584:2485-90
    למחקר

2011

  • Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression.
    Bar-Yishay, I., Shaul, Y., and Shlomai A.
    Liver Int 2011;31:282-290
    למחקר
  • Sampling variability of transient elastography according to probe location.
    Zelber-Sagi S, Yeshua H, Shlomai A, Blendis L, Leshno M, Levit S, Halpern Z, Oren R.
    Eur J Gastroenterol Hepatol. 2011;23:507-14
    למחקר
  • Diagnostic and prognostic value of thrombocytosis in admitted medical patients.
    Tchebiner JZ, Nutman A, Boursi B, Shlomai A, Sella T, Wasserman A. Guzner-Gur H.
    Am J Med Sci. 2011;342:395-401
    למחקר
  • Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase.
    Ben-Shlomo S, Zvibel I, Shnell M, Shlomai A, Chepurko E, Halpern Z, Barzilai N, Oren R, Fishman S.
    J Hepatol. 2011;54:1214-23
    למחקר
  • Targeting late SV40 factor: Is the achilles heel of hepatocarcinogenesis revealed?
    Shlomai, A.
    World J Gastroenterol 2011;18:6709-6711
    למחקר

2012

  • Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up.
    Zelber-Sagi S, Lotan R, Shlomai A, Webb M, Harrari G, Buch A, Nitzan Kaluski D, Halpern Z, Oren R.
    J Hepatol. 2012;56:1145-51
    למחקר
  • The metabolic regulator PGC-1alpha links hepatitis C virus infection to hepatic insulin resistance.
    Shlomai A, Rechtman MM, Burdelova EO, Zilberberg A, Hoffman S, Solar I, Fishman S, Halpern Z, Sklan EH.
    J Hepatol. 2012;57:867-73
    למחקר
  • Perinephric and epididymal fat affect hepatic metabolism in rats.
    Ben-Shlomo S, Einstein FH, Zvibel I, Atias D, Shlomai A, Halpern Z, Barzilai N, Fishman S.
    Obesity (Silver Spring). 2012;20:151-6
    למחקר
  • Guidelines for diagnosis and management of cirrhotic ascites and its complications.
    Sikuler, E., Ackerman, Z., Braun, M., Baruch, Y., Bruck, R., Safadi, R., Shlomai A. and Ben-Ari, Z.
    Harefua 2012. 151:705-708, 719
    למחקר

2013

  • The Protein Level of PGC-1 alpha, a Key Metabolic Regulator, Is Controlled by NADH-NQO1.
    Adamovich Y, Shlomai A, Tsvetkov P, Umansky KB, Reuven N, Estall JL, Spiegelman BM, Shaul Y.
    Mol Cell Biol. 2013;33:2603-13
    למחקר
  • Serum bile acid levels as a predictor for the severity of liver fibrosis in patients with chronic hepatitis C.
    Shlomai A, Halfon P, Goldiner I, Zelber-Sagi S, Halpern Z, Oren R, Bruck R.
    J Viral Hepat. 2013;20:95-102
    למחקר
  • The metabolic regulator PGC-1alpha links anti-cancer cytotoxic chemotherapy to reactivation of hepatitis B virus.
    Mouler Rechtman M, Burdelova EO, Bar-Yishay I, Ben-Yehoyada M, Fishman S, Halpern Z, Shlomai A.
    J Viral Hepat. 2013;20:34-41
    למחקר
  • Role of Glucose-Dependent Insulinotropic Polypeptide in Adipose Tissue Inflammation of Dipeptidylpeptidase 4-Deficient Rats.
    Ben-Shlomo S, Zvibel I, Varol C, Spektor L, Shlomai A, Santo EM, Halpern Z, Oren R, Fishman S.
    Obesity (Silver Spring). 2013;21:2331-41
    למחקר
  • Dipeptidyl Peptidase 4-Deficient Rats Have Improved Bile Secretory Function in High Fat Diet-Induced Steatosis.
    Ben-Shlomo S, Zvibel I, Rabinowich L, Goldiner I, Shlomai A, Santo EM, Halpern Z, Oren R, Fishman S.
    Dig Dis Sci. 2013;58(1):172-8
    למחקר

2014

  • Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems.
    Shlomai A, Schwartz RE, Ramanan V, Bhatta A, de Jong YP, Bhatia SN, Rice CM.
    Proc Nat Acad Sci. 2014;111:12193-12198
    למחקר
  • Getting Rid of a Persistent Troublemaker to Cure Hepatitis.
    Shlomai, A., and Rice, C.M.
    Science 2014;343:1212-1213
    למחקר
  • Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma.
    Shlomai, A., de Jong, Y.P., and Rice, C.M.
    Seminars in Cancer Biology. 2014;26:78-88
    למחקר

2015

  • Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens.
    March S, Ramanan V, Trehan K, Ng S, Galstian A, Gural N, Scull MA, Shlomai A, Mota MM, Fleming HE, Khetani SR, Rice CM, Bhatia SN.
    Nat Protoc. 2015;10(12):2027-53
    למחקר
  • Hepatitis B virus induces RNR-R2 expression via DNA damage response activation.
    Ricardo-Lax I, Ramanan V, Michailidis E, Shamia T, Reuven N, Rice CM, Shlomai A, Shaul Y.
    J Hepatol. 2015 Oct;63(4):789-96
    למחקר
  • CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus.
    Ramanan V, Shlomai A, Cox DBT, Schwartz RE, Michailidis E, Bhatta A, Scott DA, Zhang F, Rice CM, Bhatia SN.
    Sci Rep. 2015 Jun 2;5:10833
    למחקר
  • Hepatitis C virus addiction to liver miR-122 takes its toll on the host.
    Shlomai A.
    Hepatology 2015;62(5):1633-5
    למחקר
  • Multiple liver lesions after oxaliplatin-based chemotherapy for colorectal cancer.
    Shlomai A, Tobar A, Benjaminov O.
    Gastroenterology 2015;149(6):e1-3
    למחקר

2016

  • Hepatitis C virus cures after direct acting antiviral-related drug-induced liver injury: Case report.
    Hasin Y, Shteingart S, Dahari H, Gafanovich I, Floru S, Braun M, Shlomai A, Verstandig A, Dery I, Uprichard SL, Cotler SJ, Lurie Y.
    World J Hepatol 2016; 8(20): 858-862
    למחקר
  • New therapies for chronic hepatitis B.
    Bitton Alaluf M and Shlomai A.
    Liver International 2016;36(6):775-782
    למחקר
  • Advances and Challenges in Studying Hepatitis B Virus In Vitro.
    Witt-Kehati D, Bitton Alaluf M, Shlomai A.
    Viruses 2016;8:21
    למחקר
  • Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells.
    Billerbeck E, Mommersteeg MC, Shlomai A, Xiao JW, Andrus L, Bhatta A, Vercauteren K, Michailidis E, Dorner M, Krishnan A, Charlton MR, Chiriboga L, Rice CM, de Jong YP.
    J Hepatol. 2016;65(2):334-43
    למחקר
  • A Broad RNA Virus Survey Reveals Both miRNA Dependence and Functional Sequestration.
    Scheel Troels KH, Luna Joseph M, Liniger M, Nishiuchi E, Rozen-Gagnon K, Shlomai A, Auray G, Gerber M, Fak J, Keller I, Bruggmann R, Darnell RB, Ruggli N, Rice CM.
    Cell Host Microbe 2016;19(3):409-23
    למחקר

2017

  • A robust cell culture system supporting the complete life cycle of hepatitis B virus.
    Michailidis E, Pabon J, Xiang K, Park P, Ramanan V, Hoffmann H-H, Schneider WM, Bhatia SN, de Jong YP, Shlomai A, Rice CM.
    Scientific reports 2017;7(1):16616
    למחקר
  • AST to Platelet Ratio Index and fibrosis 4 calculator scores for non-invasive assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease.
    Peleg N, Issachar A, Sneh-Arbib O, Shlomai A.
    Dig Liver Dis. 2017; 49(10):1133-1138
    למחקר
  • Simultaneous Liver Transplantation and Sleeve Gastrectomy: Prohibitive Combination or a Necessity?
    Nesher E, Mor E, Shlomai A, Naftaly-Cohen M, Yemini R, Yussim A, Brown M, Keidar A.
    Obes Surg 2017;27(5):1387-1390
    למחקר
  • Patients' Age Rather Than Model of End-Stage Liver Disease Score Predicts Survival After Liver Transplantation.
    Leibovici-Weissman Y, Mor E, Leshno M, Shlomai A.
    Dig Dis Sci. 2017;62(3):801-807
    למחקר
  • HCV genotype-1 subtypes and resistance-associated substitutions in drug-naive and in direct-acting antiviral treatment failure patients.
    Gozlan Y, Ben-Ari Z, Moscona R, Shirazi R, Rakovsky A, Kabat A, Veizman E, Berdichevski T, Weiss P, Cohen-Ezra O, Lurie Y, Gafanovich I, Braun M, Cohen-Naftaly M, Shlomai A, Shibolet O, Zigmond E, Zuckerman E, Carmiel-Haggai M, Nimer A, Hazzan R, Maor Y, Kitay-Cohen Y, Shemer Y, Kra-Oz Z, Schreiber L, Peleg O, Mendelson E, Mor O.
    Antivir Ther. 2017; 22(5):431-441
    למחקר

2018

  • Characterization of hepatitis B and delta coinfection in Israel.
    Shirazi R, Ram D, Rakovsky A, Bucris E, Gozlan Y, Lustig Y, Shaked-Mishan P, Picard O, Shemer-Avni Y, Ben-Zvi H, Halutz O, Lurie Y, Veizman E, Carlebach M, Braun M, Naftaly MC, Shlomai A, Safadi R, Mendelson E, Sklan EH, Ben-Ari Z, Mor O.
    BMC Infect Dis. 2018;18(1):97
    למחקר
  • Inhibition of pMAPK14 Overcomes Resistance to Sorafenib in Hepatoma Cells with Hepatitis B Virus.
    Witt-Kehati D, Fridkin A, Alaluf MB, Zemel R, Shlomai A.
    Transl Oncol. 2018;11(2):511-517
    למחקר
  • The antiviral protein Viperin suppresses T7 promoter dependent RNA synthesis-possible implications for its antiviral activity.
    Dukhovny A., Shlomai A., and Sklan E. H.
    Scientific reports 2018; 8, 8100
    למחקר
  • Noninvasive scoring systems predict hepatic and extra-hepatic cancers in patients with nonalcoholic fatty liver disease.
    Peleg N., Sneh Arbib O., Issachar A., Cohen-Naftaly M., Braun M., and Shlomai A.
    PLOS ONE 2018 13(8), e0202393
    למחקר
  • The Effect of Cause, Timing, Kidney Function Recovery and Recurrent Events on the Prognosis of Acute Kidney Injury in Kidney Transplant Recipients.
    Van Dijk T. Y., Rahamimov R., Chagnac A., van Dijk D. J., Mor E., Shlomai A., and Rozen-Zvi B.
    Clinical Transplantation, 2018 Oct;32(10):e13398
    למחקר
  • Regorafenib treatment for patients with hepatocellular carcinoma who progressed on sorafenib-A cost-effectiveness analysis.
    Shlomai A., Leshno M., and Goldstein D. A.
    PLOS ONE 2018 13 (11), e0207132
    למחקר
  • Transplantation of Livers from Old Donors: Pushing the Envelope Beyond the Seventh Decade.
    Nesher E., Braun M., Eizner S., Issachar A., Cohen M., Shlomai A., Gurevich M., Tur-Kaspa R., and Mor E.
    Isr Med Assoc J. 2018 20, 765-769
    למחקר
  • Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection. (Letter to the Editor)
    Wiessman, M and Shlomai A.
    The New England Journal of Medicine 2018;378(26) 2539
    למחקר

2019

  • High frequency of multiclass HCV resistance-associated mutations in patients failing direct-acting antivirals: real-life data.
    Gozlan Y., Bucris E., Shirazi R., Rakovsky A., Ben-Ari Z., Davidov Y., Veizman E., Saadi T., Braun M., Cohen-Naftaly M., Shlomai A., Shibolet O., Zigmond E., Katchman H., Menachem Y., Safadi R., Galun E., Zuckerman E., Nimer A., Hazzan R., Maor Y., Saif A. M., Etzion O., Lurie Y., Mendelson E., and Mor O.
    Antiviral therapy. 2019 24(3):221-228
    למחקר
  • Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral load
    Peleg N, Issachar A, Sneh Arbib O, Cohen-Naftaly M, Braun M, Leshno M, Barsheshet A, Shlomai A.
    JHEP Reports. 2019 1 pp. 8-14
    למחקר
  • The Pattern of Elevated Liver Function Tests in Nonalcoholic Fatty Liver Disease Predicts Fibrosis Stage and Metabolic-Associated Comorbidities.
    Shirin D., Peleg N., Sneh-Arbib O., Cohen-Naftaly M., Braun M., Shochat T., Issachar A., and Shlomai A.
    Digestive Diseases 2019;37(1):69-76
    למחקר
  • Liver steatosis is a major predictor of poor outcomes in chronic hepatitis C patients with sustained virologic response
    Peleg N, Issachar A, Sneh-Arbib O, Cohen-Naftaly M, Harif Y, Oxtrud E, Braun M, Leshno M, Barsheshet A, Shlomai A.
    J Viral Hepatitis 2019 26(11):1257-1265
    למחקר
  • Cabozantinib for patients with advanced hepatocellular carcinoma - a cost-effectiveness analysis
    Shlomai A, Leshno M and Goldstein DA.
    Therapeutic Advances in Gastroenterology 2019. Sep 23;12:1756284819878304
    למחקר

2020

  • Fatal invasive Apophysomyces variabilis infection in a frequent traveler to Mecca, Saudi Arabia
    Shafran, N., Atamna, A., Inbar, E., Soudry, E., Sternov, Y., Saleh, L., Zvi, H. B., Shlomai, A., and Bishara, J.
    Journal of Travel Medicine
    למחקר
  • Role of noninvasive tests on the prediction of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without cirrhosis: a systematic review and meta-analysis of aggregate and individual patient data
    Siriwong, N., Sriphoosanaphan, S., Decharatanachart, P., Yongpisarn, T., Kerr, S. J., Treeprasertsuk, S., Tiyarattanachai, T., Apiparakoon, T., Hagstrom, H., Akbari, C., Ekstedt, M., Yip, T. C., Wong, G. L., Ito, T., Ishigami, M., Toyoda, H., Peleg, N., Shlomai, A., Seko, Y., Sumida, Y., Kawanaka, M., Hino, K., and Chaiteerakij, R.
    Eur J Gastroenterol Hepatol 37, 358-369
    למחקר
  • Clinical outcomes of immunomodulation therapy in immunocompromised patients with severe Covid-19 and high oxygen requirement
    Goldstein, A., Neuberger, A., Darawsha, Y. Q., Hussein, K., Shafat, T., Grupel, D., Strahilevitz, J., Israel, S., Weil, A., Ben-Ami, R., Elbaz, M., Najjar-Debbiny, R., Bishara, J., Shlomai, A., and Landes, M.
    Sci Rep 14, 16985
    למחקר
  • Deep mutational scanning of hepatitis B virus reveals a mechanism for cis-preferential reverse transcription
    Yu, Y., Kass, M. A., Zhang, M., Youssef, N., Freije, C. A., Brock, K. P., Aguado, L. C., Seifert, L. L., Venkittu, S., Hong, X., Shlomai, A., de Jong, Y. P., Marks, D. S., Rice, C. M., and Schneider, W. M.
    Cell 187, 2735-2745 e2712
    למחקר
  • Steatosis, HBV-related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta-analysis
    Mao, X., Cheung, K. S., Peng, C., Mak, L. Y., Cheng, H. M., Fung, J., Peleg, N., Leung, H. H., Kumar, R., Lee, J. H., Shlomai, A., Yuen, M. F., and Seto, W. K.
    Hepatology 77, 1735-1745
    למחקר
  • A decision-making model for prediction of a stable disease course in chronic hepatitis B patients
    Ofri, I., Peleg, N., Leshno, M., and Shlomai, A.
    Sci Rep 13, 23051
    למחקר
  • Post liver transplantation anemia and its correlation with mortality and graft Failure.
    Berger T, Reisler I, Shochat T, Raanani P, Mor E, Gafter-Gvili A, Shlomai A.
    Digestive Diseases and Sciences 2020 Oct;65(10):3040-3051
    למחקר
  • Expansion, in vivo-ex vivo cycling, and genetic manipulation of primary human hepatocytes.
    Michailidis, E., K. Vercauteren, L. Mancio-Silva, L. Andrus, C. Jahan, I. Ricardo-Lax, C. Zou, M. Kabbani, P. Park, C. Quirk, C. Pyrgaki, B. Razooky, L. Verhoye, I. Zoluthkin, W. Y. Lu, S. J. Forbes, L. Chiriboga, N. D. Theise, R. W. Herzog, H. Suemizu, W. M. Schneider, A. Shlomai, P. Meuleman, S. N. Bhatia, C. M. Rice and Y. P. de Jong.
    Proc Natl Acad Sci U S A 2020 117(3): 1678-1688
    למחקר
  • Ombitasvir/paritaprevir/ritonavir & dasabuvir plus/minus ribavirin following protease inhibitors failure - a prospective multi-center trial.
    Deutsch L, Houri I, Ben-Ari Z, Shlomai A, Veitsman E, Cohen-Ezra O, Issachar A, Mor O, Gozlan Y, Bruck R, Menachem Y, Zelber-Sagi S, Katchman H, Shibolet O.
    BMC Infect Dis 2020 Apr 3;20(1):264
    למחקר
  • Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis.
    Taylor, R. S., R. J. Taylor, S. Bayliss, H. Hagstrom, P. Nasr, J. M. Schattenberg, M. Ishigami, H. Toyoda, V. Wai-Sun Wong, N. Peleg, A. Shlomai, G. Sebastiani, Y. Seko, N. Bhala, Z. M. Younossi, Q. M. Anstee, S. McPherson and P. N. Newsome.
    Gastroenterology 2020 Feb 4:S0016-5085(20)30137-2
    למחקר
  • Nasopharyngeal viral load predicts hypoxemia and disease outcome in admitted COVID-19 patients.
    Shlomai, A., H. Ben-Zvi, A. Glusman Bendersky, N. Shafran, E. Goldberg and E. H. Sklan.
    Critical care 2020; 24(1): 539-539
    למחקר
  • Response guided therapy for reducing duration of direct acting antivirals in chronic hepatitis C infected patients: a Pilot study.
    Etzion, O., H. Dahari, D. Yardeni, A. Issachar, A. Nevo-Shor, M. Cohen-Naftaly, Y. Ashur, S. L. Uprichard, O. S. Arbib, D. Munteanu, M. Braun, S. J. Cotler, N. Abufreha, A. Keren-Naus, Y. Shemer-Avni, O. Mor, J. Murad, V. Novack and A. Shlomai.
    Scientific Reports 2020; 10: 17820
    למחקר
  • Acute liver failure is regulated by MYC- and microbiome-dependent programs.
    Kolodziejczyk, A. A., S. Federici, N. Zmora, G. Mohapatra, M. Dori-Bachash, S. Hornstein, A. Leshem, D. Reuveni, E. Zigmond, A. Tobar, T. M. Salame, A. Harmelin, A. Shlomai, H. Shapiro, I. Amit and E. Elinav.
    Nature Medicine 2020 Dec;26(12):1899-1911
    למחקר

2021

  • Early HBV RNA kinetics under NA treatment may reveal new insights into HBV RNA dynamics and NA mode of action-more detailed kinetic studies are needed.
    Dahari, H., Shlomai, A., and Cotler, S. J.
    Journal of Viral Hepatitis 2021 Apr;28(4):687-688
    למחקר
  • A real-life setting evaluation of the effect of remdesivir on viral load in COVID-19 patients admitted to a large tertiary center in Israel.
    Goldberg, E., H. Ben Zvi, L. Sheena, S. Sofer, I. Krause, E. H. Sklan and A. Shlomai
    Clinical Microbiology and Infection 2021 Jun; 27(6): 917.e1-917.e4
    למחקר
  • Abnormal liver tests in patients with SARS-CoV-2 or influenza-prognostic similarities and temporal disparities.
    Shafran N, Issachar A, Shochat T, Shafran IH, Bursztyn M, Shlomai A.
    JHEP Reports. 2021 Jun;3(3):100258
    למחקר
  • Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients.
    N. Shafran, I. Shafran, H. Ben-Zvi, S. Sofer, L. Sheena, I. Krause, A. Shlomai, E. Goldberg and E. H. Sklan
    Scientific Reports 2021 11(1): 12703
    למחקר
  • Modeling Social Distancing Strategies to Prevent SARS-CoV-2 Spread in Israel: A Cost-Effectiveness Analysis.
    Shlomai, A., Leshno, A., Sklan, E. H., and Leshno, M.
    Value in Health 2021 May;24(5):607-614
    למחקר

2022

  • Machine learning for mathematical models of HCV kinetics during antiviral therapy
    Churkin, A., Kriss, S., Uziel, A., Goyal, A., Zakh, R., Cotler, S. J., Etzion, O., Shlomai, A., Rotstein, H. G., Dahari, H., and Barash, D.
    Math Biosci 2022 Jan:343:108756
    למחקר
  • Modeling-Based Response-Guided DAA Therapy for Chronic Hepatitis C to Identify Individuals for Shortening Treatment Duration
    Goyal, A., Churkin, A., Barash, D., Cotler, S. J., Shlomai, A., Etzion, O., and Dahari, H.
    Open Forum Infect Dis 2022 Mar 22;9(5):ofac157
    למחקר
  • Elevated Serum Amyloid A Levels Contribute to Increased Platelet Adhesion in COVID-19 Patients
    Siman-Tov, R., Shalabi, R., Shlomai, A., Goldberg, E., Essa, W., Shusterman, E., Ablin, J. N., Caspi, M., Rosin-Arbesfeld, R., and Sklan, E. H.
    Int J Mol Sci 2022 Nov 17;23(22):14243
    למחקר
  • A genome-wide CRISPR activation screen reveals Hexokinase 1 as a critical factor in promoting resistance to multi-kinase inhibitors in hepatocellular carcinoma cells
    Sofer, S., Lamkiewicz, K., Armoza Eilat, S., Partouche, S., Marz, M., Moskovits, N., Stemmer, S. M., Shlomai, A., and Sklan, E. H.
    FASEB J 2022 Mar;36(3):e22191
    למחקר

2023

  • Immunogenicity of a Third Dose of BNT162b2 Vaccine among Lung Transplant Recipients-A Prospective Cohort Study
    Shostak, Y., Kramer, M. R., Edni, O., Glusman Bendersky, A., Shafran, N., Bakal, I., Heching, M., Rosengarten, D., Shitenberg, D., Amor, S. M., Ben Zvi, H., Pertzov, B., Cohen, H., Rotem, S., Elia, U., Chitlaru, T., Erez, N., Peysakhovich, Y., Y, D. B., Shlomai, A., Bar-Haim, E., and Shtraichman, O.
    Vaccines (Basel) 2023 Apr 4;11(4):799
    למחקר
  • An RNA-based system to study hepatitis B virus replication and evaluate antivirals
    Yu, Y., Schneider, W. M., Kass, M. A., Michailidis, E., Acevedo, A., Pamplona Mosimann, A. L., Bordignon, J., Koenig, A., Livingston, C. M., van Gijzel, H., Ni, Y., Ambrose, P. M., Freije, C. A., Zhang, M., Zou, C., Kabbani, M., Quirk, C., Jahan, C., Wu, X., Urban, S., You, S., Shlomai, A., de Jong, Y. P., and Rice, C. M.
    Sci Adv 2023 Apr 14;9(15):eadg6265
    למחקר

2026

  • Cell-based platforms for antiviral screening against hepatitis B virus: advantages, limitations, and future perspectives.
    Taylor M. Shue, Allan Henrique Depieri Cataneo, Antonis Athanasiadis, Christopher E. Jones, Ype P. de Jong, Amir Shlomai, Eleftherios Michailidis
    Antivir. Res. 106450 (2026)
    למחקר

ראש/ת המעבדה

פרופ' אמיר שלומאי

מנהל/ת המעבדה

דר' נדב אלקושי

איש קשר

  • לריסה עינב (MPH) - רכזת מחקר קליני

יצירת קשר

ליצירת קשר עם חקר הכבד, השאירו פרטים: